|
|
|
Volumn 57, Issue , 2009, Pages
|
|
The decreased number of new drug approvals (NDAs) has been a topic of considerable debate over the past decade. Preface.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANIMAL;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG DESIGN;
DRUG INDUSTRY;
ECONOMICS;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
UNITED STATES;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 75549089768
PISSN: None
EISSN: 15578925
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
